Autologous BMT in high risk patients with CALLA-positive ALL: Possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement

Y. Morishima, K. Miyamura, S. Kosjima, R. Ueda, Y. Morishita, H. Sao, M. Tanimoto, R. Ohno, R. Sobue, M. Hirano, H. Sakamaki, S. Takamoto, K. Imai, Y. Onozawa, S. Yokomaku, Y. Kato, S. Tsuzuki, Y. Akatsuka, S. Minami

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Fingerprint Dive into the research topics of 'Autologous BMT in high risk patients with CALLA-positive ALL: Possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement'. Together they form a unique fingerprint.

Medicine & Life Sciences